Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
102.4 USD | +0.83% | +0.48% | +22.63% |
May. 07 | UBS Adjusts Cabot Price Target to $103 From $100, Maintains Neutral Rating | MT |
May. 07 | Mizuho Adjusts Price Target on Cabot to $109 From $104, Maintains Buy Rating | MT |
Financials (USD)
Sales 2024 * | 3.99B | Sales 2025 * | 4.25B | Capitalization | 5.66B |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.65 x |
Net Debt 2024 * | 947M | Net Debt 2025 * | 914M | EV / Sales 2025 * | 1.55 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 4,268 |
Yield 2024 * |
1.65% | Yield 2025 * |
1.79% | Free-Float | 98.62% |
Latest transcript on Cabot Corporation
1 day | +0.83% | ||
1 week | +0.48% | ||
Current month | +12.24% | ||
1 month | +12.91% | ||
3 months | +25.32% | ||
6 months | +30.73% | ||
Current year | +22.63% |
Managers | Title | Age | Since |
---|---|---|---|
Sean Keohane
CEO | Chief Executive Officer | 56 | 02-07-31 |
Erica McLaughlin
DFI | Director of Finance/CFO | 48 | 02-03-31 |
Patricia Hubbard
CTO | Chief Tech/Sci/R&D Officer | 56 | 18-02-04 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Kirby
BRD | Director/Board Member | 72 | 12-07-09 |
Sean Keohane
CEO | Chief Executive Officer | 56 | 02-07-31 |
Ying Yan
BRD | Director/Board Member | 58 | 19-05-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.17% | 43 M€ | +4.49% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 102.4 | +0.83% | 199,078 |
24-05-16 | 101.6 | -0.10% | 279,852 |
24-05-15 | 101.7 | -0.55% | 267,570 |
24-05-14 | 102.2 | +0.05% | 266,357 |
24-05-13 | 102.2 | +0.26% | 263,308 |
Delayed Quote Nyse, May 17, 2024 at 04:00 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+22.63% | 5.66B | |
+17.80% | 66.73B | |
+2.92% | 49.79B | |
+19.98% | 42.5B | |
+20.88% | 26.45B | |
+12.04% | 19.66B | |
+1.27% | 17.18B | |
-22.98% | 15.82B | |
+2.77% | 15.56B | |
-9.25% | 15.41B |
- Stock Market
- Equities
- CBT Stock